CLSD
Clearside Biomedical (CLSD)
$45
About Clearside Biomedical (CLSD)
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Details
Daily high
$1.45
Daily low
$1.28
Price at open
$1.32
52 Week High
$2.12
52 Week Low
$0.65
Market cap
108.4M
Dividend yield
0.00%
Volume
502,945
Avg. volume
439,783
P/E ratio
-2.92
Clearside Biomedical News
Details
Daily high
$1.45
Daily low
$1.28
Price at open
$1.32
52 Week High
$2.12
52 Week Low
$0.65
Market cap
108.4M
Dividend yield
0.00%
Volume
502,945
Avg. volume
439,783
P/E ratio
-2.92